Digital imaging-assisted quantification of H3K27me3 immunoexpression in luminal A/B-like, HER2-negative, invasive breast cancer predicts patient survival and risk of recurrence

MLA

Mário Fontes-Sousa, et al. “Digital Imaging-Assisted Quantification of H3K27me3 Immunoexpression in Luminal A/B-like, HER2-Negative, Invasive Breast Cancer Predicts Patient Survival and Risk of Recurrence.” Molecular Medicine, vol. 26, no. 1, Feb. 2020, pp. 1–9. EBSCOhost, https://doi.org/10.1186/s10020-020-0147-5.

APA

Mário Fontes-Sousa, João Lobo, Silvana Lobo, Sofia Salta, Maria Amorim, Paula Lopes, Luís Antunes, Susana Palma de Sousa, Rui Henrique, & Carmen Jerónimo. (2020). Digital imaging-assisted quantification of H3K27me3 immunoexpression in luminal A/B-like, HER2-negative, invasive breast cancer predicts patient survival and risk of recurrence. Molecular Medicine, 26(1), 1–9. https://doi.org/10.1186/s10020-020-0147-5

Chicago

Mário Fontes-Sousa, João Lobo, Silvana Lobo, Sofia Salta, Maria Amorim, Paula Lopes, Luís Antunes, Susana Palma de Sousa, Rui Henrique, and Carmen Jerónimo. 2020. “Digital Imaging-Assisted Quantification of H3K27me3 Immunoexpression in Luminal A/B-like, HER2-Negative, Invasive Breast Cancer Predicts Patient Survival and Risk of Recurrence.” Molecular Medicine 26 (1): 1–9. doi:10.1186/s10020-020-0147-5.